SAN DIEGO, July 23, 2025 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Easterly ROCMuni High Income Municipal Bond Fund f/k/a Principal Street High Income Municipal Fund (the “Easterly ROCMuni Fund”) (NASDAQ: RMJAX; RMHVK; RMHIX) shares between May 5, 2023 and June 12, 2025, inclusive (the “Class Period”), […]

SAN DIEGO, July 23, 2025 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596 (C.D. Cal.) – seeks to represent purchasers or acquirers of RxSight, Inc. (NASDAQ: RXST) securities and charges certain of RxSight’s top executives with

NEWTOWN, Pa., July 23, 2025 /PRNewswire/ — Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Encompass Health Corporation (“Encompass”) (NYSE: EHC), resulting from allegations of providing potentially misleading information to the investing public. If you are an Encompass investor who suffered a substantial loss and would like to learn more, you can

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering, combination strategies, and biomarker testing, this therapeutic class is set to play a transformative role in the next generation of precision oncology. LAS VEGAS, July 23, 2025 /PRNewswire/ — DelveInsight’s Claudin